- It was listed on BME Growth in July 2016
Next Monday, February 7th, the shares that make up the stock capital of Atrys Health, listed on BME Growth, will be traded on the stock exchange, following the approval by the Spanish securities market supervisor (CNMV). The shares will be traded under the code "ATRY".
The share's closing price on BME Growth on Friday, February 4th, will be used as the reference price for the start of trading. The opening auction will begin at 8:30 am on Monday and will end at 12:00 pm, following the shares’ admission to trading.
Atrys Health was listed on BME Growth in July 2016 and has carried out several capital increase transactions which have paved the way for its international expansion. It has also relied on BME's Fixed Income market, MARF, to diversify its financing sources via bond issuance programmes. The company, which specialises in innovative oncology diagnosis and treatment services, is the third one to move from the SME Growth market to the stock exchange, following MásMóvil and Grenergy.
"This is a clear example of how companies can increase their size significantly by building upon the recurring funding they receive as they tap the capital markets," says Beatriz Alonso-Majagranzas, Head of BME Exchange.
|
BME Growth
